F
Amicus Therapeutics D
D
FOLD
14.210
USD
3.32
(30.43%)
مغلق
حجم التداول
6,654,014
الربح لكل سهم
0
العائد الربحي
-
P/E
-354
حجم السوق
4,384,261,717
الأخبار المقالات
العنوان: Amicus Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants;a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.